2026 · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · open access
Diagnostic Performance of the Pluslife MiniDock MTB and Molbio MTB Ultima Assays to Detect Tuberculosis From Tongue and Sputum Swabs Among Outpatients and in Active Case Finding in Cameroon
Mbuli et al.
The finding, in our words
The study found that the MiniDock MTB and MTB Ultima assays showed similar diagnostic performance on tongue swabs and sputum samples, with sensitivities ranging from 76% to 86% for culture-positive tuberculosis, suggesting that tongue swabs could be a viable alternative to sputum for near point-of-care testing.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.
The study found that self-collected dried saliva on FishburneTabs achieved 92% accuracy for viral RNA detection compared to standard liquid saliva samples. This method supports decentralised testing by enabling reliable sample storage and transport for upper respiratory infections.
Mora et al., ACS measurement science au · source ↗
A triple-channel immunochromatographic system using quantum dots detected influenza A and B and SARS-CoV-2 nucleoproteins in saliva with limits of detection from 0.227 to 0.348 ng/mL. Testing of 15 influenza A patients and 20 healthy controls showed 100% sensitivity and 95.2% specificity, indicating potential for accurate home-based respiratory virus screening.
The COVID-19 pandemic accelerated adoption of decentralised testing and self-collected saliva specimens, but revealed challenges with variable diagnostic accuracy and lack of internationally standardised processing protocols. Stricter regulatory oversight and robust diagnostic stewardship are needed to balance broad access with clinical performance.
This review summarises how incorporating saliva and urine into home-based point-of-care systems expands diagnostic accessibility for dengue virus, aligning with the WHO REASSURED framework for affordable and rapid testing.
Shi et al., Journal of medical virology (paywalled) · source ↗
Capillary blood self-collected with the VAMS device showed 100 per cent agreement with serum for detecting SARS-CoV-2 S RBD antibodies in participants with known past infection, and saliva showed slightly lower but high agreement; agreement was good to almost perfect in those without known antibodies, and most participants found finger prick easy while half found the microsampler easy, supporting decentralised serosurveillance.